CASE DESCRIPTION: 3 adult (24- to 43-year-old) Atlantic bottlenose dolphins (Tursiops truncatus) with chronic episodic malaise and inappetence associated with high serum aminotransferase (alanine aminotransferase and aspartate aminotransferase) activities, high serum iron concentration, and serum transferrin saturation > 80% were evaluated. CLINICAL FINDINGS: Results of histologic examination of liver biopsy specimens revealed hemosiderosis in all 3 dolphins. Except for chronic lymphocytosis in 1 dolphin, results of extensive diagnostic testing revealed no other abnormalities. For each dolphin, a diagnosis of iron overload of unknown origin was made. TREATMENT AND OUTCOME: Phlebotomy treatment was implemented to reduce body stores of iron. Each phlebotomy procedure removed 7% to 17% (1 to 3 L) of estimated blood volume. Treatment consisted of an induction phase of weekly phlebotomy procedures for 22 to 30 weeks, which was complete when serum iron concentration and aminotransferase activities were within reference ranges and serum transferrin saturation was < or = 20% or Hct was < or = 30%. Total amount of iron removed from each dolphin was 53 to 111 mg/kg (24.1 to 50.5 mg/lb) of body weight. One dolphin required maintenance procedures at 8- to 12-week intervals when high serum iron concentration was detected. CLINICAL RELEVANCE: Although the cause of the iron overload and high serum aminotransferase activities remained unknown, phlebotomy treatment successfully resolved the clinicopathologic abnormalities, supporting a role of iron overload in the hepatopathy of the 3 dolphins.
CASE DESCRIPTION: 3 adult (24- to 43-year-old) Atlantic bottlenose dolphins (Tursiops truncatus) with chronic episodic malaise and inappetence associated with high serum aminotransferase (alanine aminotransferase and aspartate aminotransferase) activities, high serum iron concentration, and serum transferrin saturation > 80% were evaluated. CLINICAL FINDINGS: Results of histologic examination of liver biopsy specimens revealed hemosiderosis in all 3 dolphins. Except for chronic lymphocytosis in 1 dolphin, results of extensive diagnostic testing revealed no other abnormalities. For each dolphin, a diagnosis of iron overload of unknown origin was made. TREATMENT AND OUTCOME: Phlebotomy treatment was implemented to reduce body stores of iron. Each phlebotomy procedure removed 7% to 17% (1 to 3 L) of estimated blood volume. Treatment consisted of an induction phase of weekly phlebotomy procedures for 22 to 30 weeks, which was complete when serum iron concentration and aminotransferase activities were within reference ranges and serum transferrin saturation was < or = 20% or Hct was < or = 30%. Total amount of iron removed from each dolphin was 53 to 111 mg/kg (24.1 to 50.5 mg/lb) of body weight. One dolphin required maintenance procedures at 8- to 12-week intervals when high serum iron concentration was detected. CLINICAL RELEVANCE: Although the cause of the iron overload and high serum aminotransferase activities remained unknown, phlebotomy treatment successfully resolved the clinicopathologic abnormalities, supporting a role of iron overload in the hepatopathy of the 3 dolphins.
Authors: Leigh Ann Clayton; M Andrew Stamper; Brent R Whitaker; Catherine A Hadfield; Brian Simons; Joseph L Mankowski Journal: J Zoo Wildl Med Date: 2012-12 Impact factor: 0.776
Authors: Lisa M Mazzaro; Shawn P Johnson; Patricia A Fair; Greg Bossart; Kevin P Carlin; Eric D Jensen; Cynthia R Smith; Gordon A Andrews; Patricia S Chavey; Stephanie Venn-Watson Journal: Comp Med Date: 2012-12 Impact factor: 0.982
Authors: Stephanie K Venn-Watson; Celeste Parry; Mark Baird; Sacha Stevenson; Kevin Carlin; Risa Daniels; Cynthia R Smith; Richard Jones; Randall S Wells; Sam Ridgway; Eric D Jensen Journal: PLoS One Date: 2015-07-22 Impact factor: 3.240
Authors: Benjamin A Neely; Kevin P Carlin; John M Arthur; Wayne E McFee; Michael G Janech Journal: Front Endocrinol (Lausanne) Date: 2013-09-20 Impact factor: 5.555
Authors: Kirsten C Eberle; Theresa E Waters; Eric D Jensen; Stephanie K Venn-Watson; Randy E Sacco Journal: Front Endocrinol (Lausanne) Date: 2013-10-01 Impact factor: 5.555